GoodRx Holdings, Inc.GDRXNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank56
3Y CAGR+39.6%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+39.6%/yr
vs -29.2%/yr prior
Acceleration
+68.8pp
Accelerating
Percentile
P56
Within normal range
vs 3Y Ago
2.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM23.14%+19.1%
202419.43%+33.9%
202314.50%+70.6%
20228.50%+32.1%
20216.44%+113.8%
2020-46.69%-224.0%
201937.64%+11.3%
201833.80%-10.5%
201737.78%+34.1%
201628.18%-